CorMedix Inc.
CRMD
$11.50
$1.4314.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.68% | 25.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.68% | 25.22% | |||
| Cost of Revenue | 16.64% | 35.82% | |||
| Gross Profit | 1.04% | 24.81% | |||
| SG&A Expenses | 12.15% | -7.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.52% | 3.73% | |||
| Operating Income | -2.89% | 55.58% | |||
| Income Before Tax | -1.43% | 53.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3.95% | 53.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.95% | 53.32% | |||
| EBIT | -2.89% | 55.58% | |||
| EBITDA | -2.86% | 55.22% | |||
| EPS Basic | -7.74% | 44.54% | |||
| Normalized Basic EPS | -5.36% | 44.59% | |||
| EPS Diluted | -6.67% | 37.05% | |||
| Normalized Diluted EPS | -5.51% | 36.77% | |||
| Average Basic Shares Outstanding | 4.11% | 6.07% | |||
| Average Diluted Shares Outstanding | 4.27% | 12.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||